한빛사941건

• • Hy Dinh Nguyen(아주대학교)

    Interview

  • 이범진(아주대학교)

  Novel pH-Responsive Structural Rearrangement of Myristic Acid-Conjugated Quetiapine Nanosuspension for Enhanced Long-Acting Delivery Performance

  • Adv. Sci. Sep 03 2024, | https://doi.org/10.1002/advs.202405200

  • 2024.09
  • 의약학

• • 신윤수(기초과학연구원, 서울대학교)

  • 이현수(기초과학연구원, 서울대학교)

  • 김정욱(서울대학교)

  • 황석연(서울대학교)

  • 김대형(기초과학연구원, 서울대학교)

  Functional-hydrogel-based electronic-skin patch for accelerated healing and monitoring of skin wounds

  • Biomaterials Sep 03 2024, 314 S0142-9612(24)00336-3 | https://doi.org/10.1016/j.biomaterials.2024.122802

  • 2024.09
  • 바이오·의료융합
• 

  Hy Dinh Nguyen

  아주대학교

  Quetiapine (QTP) is a first-line antipsychotic drug for the treatment of schizophrenia; however, lifelong daily administration of QTP tablets is associated with a low patient acceptance profile. Accordingly, substituting oral dosage forms with long-acting injectables can potentially improve patient compliance and treatment effectiveness.

  • Adv. Sci.
  • 2024.09.11

• • 최원민(Harvard Medical School)

  Hybrid Nanoparticle-Hydrogel Systems for Drug Delivery Depots and Other Biomedical Applications

  • ACS Nano Aug 14 2024, | https://doi.org/10.1021/acsnano.4c06888

  • 2024.08
  • 바이오·의료융합

• • 문재이(서울대학교)

  • 김다슬(Havard medical school)

  • 김우진(서울대학교)

  • 신수련(Harvard Medical School/Brigham and Women’s Hospital)

  Hierarchical Chitin Nanocrystal-Based 3D Printed Dual-Layer Membranes Hydrogels: A Dual Drug Delivery Nano-Platform for Periodontal Tissue Regeneratio

  • ACS Nano Aug 20 2024, | https://doi.org/10.1021/acsnano.4c05558

  • 2024.08
  • 바이오·의료융합

• • Fakhar Ud Din(한양대학교 약학대학)

  • 김정석(한양대학교 약학대학)

  • 최한곤(한양대학교 약학대학)

  Injectable dual thermoreversible hydrogel for sustained intramuscular drug delivery

  • J. Control. Release Aug 30 2024, 374 S0168-3659(24)00584-4 | https://doi.org/10.1016/j.jconrel.2024.08.034

  • 2024.08

• • 장호충(한국과학기술연구원 (KIST))

  • 심만규(한국과학기술연구원 (KIST))

  • 양유수(한국과학기술연구원)

  Milk-derived extracellular vesicles enable gut-to-tumor oral delivery of tumor-activated doxorubicin prodrugs

  • Theranostics Published 2024-8-26;14(14):5413-5428 | doi:10.7150/thno.97269

  • 2024.08
  • 바이오·의료융합

• • 한지훈(성균관대학교, 현 Gladstone Institutes)

  • 조동규(성균관대학교)

  Engineered exosomes with a photoinducible protein delivery system enable CRISPR-Cas-based epigenome editing in Alzheimer‘s disease

  • Sci. Transl. Med. Aug 07 2024, 16 (759) | https://doi.org/10.1126/scitranslmed.adi4830

  • 2024.08
  • 의약학

• • Dinh-Huy Nguyen(전남대학교)

  • 하상준(연세대학교)

  • 홍영진(전남대학교 의과대학)

  • 민정준(전남대학교 의과대학)

  Reprogramming the tumor immune microenvironment using engineered dual-drug loaded Salmonella

  • Nat. Commun. 06 August 2024 | https://doi.org/10.1038/s41467-024-50950-5

  • 2024.08
  • 의약학

• • 여윤(Purdue University)

  Effects of nanoparticle deformability on multiscale biotransport

  • Adv. Drug Deliv. Rev. Aug 31 2024, S0169-409X(24)00267-9 | https://doi.org/10.1016/j.addr.2024.115445

  • 2024.08
  • 바이오·의료융합

• • Rakesh Bhaskar(영남대학교)

  • 한성수(영남대학교)

  Advancing the Understanding of Diabetic Encephalopathy through Unravelling Pathogenesis and Exploring Future Treatment Perspectives

  • Ageing Res. Rev. Aug 10 2024, S1568-1637(24)00268-X | https://doi.org/10.1016/j.arr.2024.102450

  • 2024.08

• • 한지은(서울대학교)

  • 최이정(서울대학교)

  • 강승균(서울대학교)

  Synergistic Strategies of Biomolecular Transport Technologies in Transdermal Healthcare Systems

  • Adv. Healthc. Mater. 01 August 2024 | https://doi.org/10.1002/adhm.202401753

  • 2024.08
  • 바이오·의료융합
• 

  김재현

  한양대학교

  본 연구는 항암 면역치료에 중점을 두고 있으며, 기존에 암 치료용 백신이 제한된 항종양 면역 반응을 보이는 문제를 극복하고자 시작되었습니다. 기존 백신은 항원의 전달과 제시가 비효율적이고, 수지상세포 및 T세포의 활성화가 최적화 되지 않아 임상적으로 한계가 있었습니다. 이를 해결하기 위해, 우리는 생체재료 기반의 나노백신을 개발하여 표적 항원 전달, 그리고 암선택적 면역반응을 유도하고 다양한 암종에 ...

  • Adv. Sci.
  • 2024.08.01

• • Ahmed M. Elbedwehy(한국표준과학연구원)

  • Jun Wu(서울대학교 의과대학)

  • 김정훈(서울대학교병원)

  • 이태걸(한국표준과학연구원)

  ROS-responsive charge reversal mesoporous silica nanoparticles as promising drug delivery system for neovascular retinal diseases

  • J. Control. Release Jul 17 2024, 373 S0168-3659(24)00453-X | https://doi.org/10.1016/j.jconrel.2024.07.022

  • 2024.07
  • 바이오·의료융합

• • 조하나(가톨릭대학교)

  • 허강무(충남대학교)

  • 강한창(가톨릭대학교 약학대학)

  Selective delivery of imaging probes and therapeutics to the endoplasmic reticulum or Golgi apparatus: Current strategies and beyond

  • Adv. Drug Deliv. Rev. Jul 04 2024, S0169-409X(24)00208-4 | https://doi.org/10.1016/j.addr.2024.115386

  • 2024.07
  • 의약학

• • 김상필(UNIST)

  • 유자형(UNIST)

  Enzyme-instructed intramitochondrial polymerization for enhanced anticancer treatment without the development of drug-resistance

  • J. Control. Release Jul 16 2024, 373 S0168-3659(24)00459-0 | https://doi.org/10.1016/j.jconrel.2024.07.029

  • 2024.07
  • 바이오·의료융합

• • 최지웅(한국과학기술연구원(KIST))

  • 심만규(한국과학기술연구원 (KIST))

  • 양유수(한국과학기술연구원 (KIST))

  Oral Delivery of Photoresponsive Milk-Derived Exosomes for the Local Therapy of Glioblastoma

  • ACS Mater. Lett. 6,4019-4027,2024 | https://doi.org/10.1021/acsmaterialslett.4c01122

  • 2024.07
  • 바이오·의료융합

• • 심가용(숭실대학교)

  • 윤유석(성균관대학교)

  Precise subcellular targeting approaches for organelle-related disorders

  • Adv. Drug Deliv. Rev. Jul 18 2024, S0169-409X(24)00233-3 | https://doi.org/10.1016/j.addr.2024.115411

  • 2024.07
  • 의약학

• • 이환규(단국대학교)

  Hydrodynamics and Aggregation of Nanoparticles with Protein Corona: Effects of Protein Concentration and Ionic Strength

  • Small Jul 31 2024, | https://doi.org/10.1002/smll.202403913

  • 2024.07
  • 바이오·의료융합

• • 이수삼(KAIST)

  • 홍경희(연세대학교)

  • 고원건(연세대학교)

  • 하상준(연세대학교)

  • 김유천(KAIST)

  Tumor phagocytosis-driven STING activation invigorates antitumor immunity and reprograms the tumor micro-environment

  • J. Control. Release Jul 04 2024, S0168-3659(24)00435-8 | https://doi.org/10.1016/j.jconrel.2024.07.004

  • 2024.07
  • 생명과학